Trinity Biotech (TRIB) Free Cash Flow (2009 - 2024)

Trinity Biotech (TRIB) has reported Free Cash Flow for 14 consecutive years, with $3.7 million the latest figure, recorded in Q4 2024.

• Quarterly Free Cash Flow rose 567.86% year-over-year to $3.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $3.7 million (up 2189.39% YoY) and the FY2025 annual result came in at -$6.0 million, down 7.33% from the prior year.
• Free Cash Flow advanced to $3.7 million in Q4 2024 per TRIB's latest filing, from -$3.9 million in the prior quarter.
• Over the last five years, Free Cash Flow for TRIB reached as high as $4.5 million in Q4 2021 and fell as low as -$7.1 million in Q2 2023.
• A 4-year average of $78127.7 and a median of $64194.5 in 2021 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2023 — Free Cash Flow sank 4985201.4% — and 2024, when it surged 567.86%.
• Year by year, Free Cash Flow stood at $4.5 million in 2021, then sank by 38.35% to $2.8 million in 2022, then plunged by 79.72% to $560000.0 in 2023, then jumped by 567.86% to $3.7 million in 2024.
• According to Business Quant data, Free Cash Flow over the past three periods registered $3.7 million, -$3.9 million, and -$3317.0 for Q4 2024, Q2 2024, and Q1 2024 respectively.